CLINICAL_TRIALS
trial_result
· 2017-11-21
Clinical Trial Update: Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis [Phase 3]
Summary
Phase 3 trial results show dupilumab monotherapy used in adults with moderate-to-severe atopic dermatitis; the study has completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Dermatitis, Atopic | Phase 3 | Status: COMPLETED | Results posted: 2017-11-21